ARCHIVES

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

Long-term Hormonal Therapy Adds No Additional Benefits

September 27, 2013

J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.

July 18, 2008

Manipulating The Therapeutic Index Clinical Trials Goal: Hellman

June 13, 1980

NCI Seeks to Maintain Grant Success Rate As Budget Deadlock Deepens on Capitol Hill

April 25, 2013

In Brief: NIDDK Begins BPH Trial; Roswell Park Honors Schwarzkopf; NRC Cites MIT

March 1, 1996

FDA Approves Gleevec In 73 Days, A Speed Record.

May 18, 2001